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Predicted COVID-19 positive cases, hospitalisations, and 
deaths associated with the Delta variant of concern, 
June–July, 2021
We previously reported on the speed with which the 
Delta variant of concern (VOC) took hold in Scotland.1 
The Delta VOC has subsequently established itself in 
many other parts of the world and has emerged as the 
dominant strain internationally.2 Recent data have 
shown that the Delta VOC is more transmissible,3 
associated with higher rates of hospitalisation than 
other variants, and that vaccines might be less effective 
in preventing infection than they are with the Alpha 
VOC.1,4 Consequently, there are concerns about the 
extent to which lockdown restrictions can safely be 
lifted, even in countries with high vaccination coverage.5
The Early Pandemic Evaluation and Enhanced 
Surveillance of COVID-19 (EAVE II) national-level 
surveillance system links multiple datasets in near real-
time providing access to individual-level data.6 We have 
used EAVE II to build data driven models to describe and 
forecast the epidemiological and clinical profile of the 
COVID-19 pandemic. Building on methods previously 
described in the context of the first and second waves 
in largely unvaccinated individuals,6 we developed 
a prediction model that estimates the likelihood of 
hospitalisation and deaths of people currently positive, 
and people predicted to be positive, with COVID-19 over 
a 4-week time horizon (appendix p 1). Specific advances 
are that we have trained the model on the Delta VOC and 
that it now also incorporates time varying vaccination 
status, school closures, and the effect of the surge in 
cases around the time of the 2020 UEFA European 
football tournament.
For forecasting, we fitted a spline model to the daily 
number of positive cases in the past 10 weeks and 
then took the number of cases from an over-dispersed 
Poisson distribution (appendix p 2). We computed the 
age and clinical risk group distribution of all patients 
who tested positive in the most recent week (beginning 
June 12, 2021; appendix p 2), and then drew a stratified 
random sample of individuals from the entire database 
who had not previously tested positive. The risk of 
hospitalisation or death was based on 26 clinical 
characteristics (comorbidities such as diabetes and 
chronic kidney disease) identified from primary care 
records that are known to increase the risk of serious 
COVID-19 outcomes.8 We thus obtained a forecasted 
cohort of individuals who were simulated to test 
positive over the ensuing 4-week time horizon.
We used a Cox regression model that took 
demographics, clinical characteristics, and vaccination 
status as inputs, and yielded probabilities of hos-
pitalisation within the next 14 days and death within 
28 days of testing positive. For each day during the 
projected 4-week time horizon, we applied the model 
to all positive cases to estimate the daily numbers of 
hospitalisations and deaths. To account for the changing 
dynamics of the pandemic—in particular, the rapid 
spreading of the Delta VOC—we retrained our model so 
that it was based on all positive cases from March 16 to 
June 7, 2021. This date range corresponds to the period 
during which the Delta VOC became the dominant strain 
in Scotland.1 Further, we have now included the ratio of 
Delta to Alpha variant to model the effect of the Delta 
VOC on risks of hospitalisation and death in addition 
to the temporal trend term to allow for additional 
temporal factors not explicitly modelled.
Our initial model, based upon all data on cases in 
Scotland up to June 19, 2021, predicted that the number 
of daily positive cases could rise to 3349 (exceeding 
the maximum of 3146 cases during the second wave), 
leading to 105 daily COVID-19 hospitalisations (44% of 
the maximum 240 during the second wave; appendix 
p 3) and 7 daily COVID-19 deaths (9% of the 76 maximum 
during the second wave; appendix p 3) by July 19, 2021, 
the cutoff date when most of the lockdown restrictions 
in Scotland were lifted. However, after factoring in 
summer holiday school closures from June 25, and the 
assumed 50% growth reduction in the increase of new 
cases from July 2, our adjusted model suggests that, 
by July 19, the daily cases could rise to 2751 cases, lead 
to 97 daily COVID-19 hospitalisations, and seven daily 
COVID-19 deaths. We subsequently observed daily cases 
exceeding 2500, daily hospitalisations reaching 100, 
and daily deaths reaching 10 during our projections 
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window. On July 19, though, there were 1908 daily cases, 
75 hospitalisations, and 8 daily deaths.
Our adjusted model also assessed the effect of 
the sudden surge in cases that likely resulted from 
widespread socialisation and mobility during the 2020 
UEFA European championship.9 During the surge in 
cases over 11 days (June 20–30), there were a median 
of 1349 excess positive cases over the originally 
forecasted positive cases (appendix p 2). In the worst-
case scenario, assuming that this surge would lead to 
an excess of 1349 cases per day in addition to those 
originally forecasted until July 19, we estimated that 
daily COVID-19 hospitalisations could potentially rise 
to 134 (56% of the maximum during the second peak) 
and the deaths to 10 (13% of the maximum during the 
second peak). Figure illustrates the daily hospitalisations 
expected on the basis of these projections with school 
closure and with (worst case) and without (best case) 
the excess cases due to the football tournament 
during the entire projection period. The most recent 
daily hospitalisation data are also superimposed on 
figure (data available until July 12) and this suggests 
that the worst-case scenario is unlikely to occur as 
the most recent hospitalisations are below the worst 
case projections in line with the observed reduction 
in cases since July 1 (appendix p 2). The appendix 
(p 4) summarises these three scenarios projected to 
July 19. The age distribution of all cases predicted to be 
hospitalised is also provided (appendix p 4).
There are limitations to our approach. Our forecasting 
approach assumes short-term exponential growth, 
which is not based on a transmission dynamic model, 
and that the current restrictions and associated mobility 
patterns will continue until July 19, 2021. Further, we 
have assumed that excess positive cases due to the 
football surge will not trigger additional exponential 
increases.
In summary, we have forecasted the number of 
COVID-19 cases, hospitalisations, and deaths in 
Scotland driven by the Delta VOC while factoring age, 
sex, comorbidities, vaccinations, school holidays, 
and potential scenarios resulting from the surge in 
cases related to UEFA EURO 2020 Championship. The 
number of daily hospitalisations forecasted during 
July 2021, is expected to increase to around 100 per day. 
Consequently, we recommend caution when proceeding 
to lift lockdown restrictions until a higher proportion 
of the population is double vaccinated than currently 
stands.
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Figure: Number of daily hospitalisations forecasted in the near future illustrating the impact of the recent 
surge in positive COVID-19 cases suspected to be triggered by UEFA EURO 2020 Championship
The purple vertical represents June 20, 2021; the beginning of our projections window in which we have forecasted 
COVID-19 positive cases, hospitalisations, and deaths. The best-case scenario represents the adjusted model that 
factors in school closure, and the worst-case scenario represents the model including excess cases due to the 
football championship. Note that the hospitalisation data in the last few days is incomplete as there is some lag 
before all data is curated at Public Health Scotland.
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